EUVIMEDEUVIMED entdecken
Crossref

A Dual-Targeted Molecule for Disease-Activatable Proteolysis Targeting Chimeras and Targeted Radionuclide Therapy of Cancer

Yuan Zhang, Wei Gu, Wan Chen, Jieli Zhu, Longfei Fan, Liwen Zhang, Liangyou Zhao, Qingqing Miao iD

Journal of the American Chemical Society · 05.03.2025 · 147 (9) · 7897-7907

DOI: 10.1021/jacs.4c18398 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 24.02.2025. Verfasst von Yuan Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Nuclear Science and Technology, University of Science and Technology of China, Hefei 230026, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Radioisotopes, Lutetium, Antineoplastic Agents. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Outstanding Youth Foundation of Jiangsu Province, Leading Talents of Innovation and Entrepreneurship of Gusu.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsRadioisotopesLutetiumAntineoplastic AgentsRadiopharmaceuticalsHumansProteolysisAnimalsCathepsin BMaleMiceCell Cycle ProteinsCell Line, TumorTranscription FactorsGlutamate Carboxypeptidase IIProteolysis Targeting ChimeraBromodomain Containing Proteins

Substanzen

Cathepsin BRadioisotopesCell Cycle ProteinsLutetiumAntineoplastic AgentsBRD4 protein, humanLutetium-177RadiopharmaceuticalsTranscription FactorsGlutamate Carboxypeptidase II

Autor:innen und Institutionen

  • School of Nuclear Science and Technology, University of Science and Technology of China, Hefei 230026, China.
  • State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions,…

ORCID-Profile: Qingqing Miao

Förderung

  • National Natural Science Foundation of China
  • Outstanding Youth Foundation of Jiangsu Province
  • Leading Talents of Innovation and Entrepreneurship of Gusu

Zitieren

APA

Zhang, Y., Gu, W., Chen, W., Zhu, J., Fan, L., Zhang, L., Zhao, L., & Miao, Q. (2025). A Dual-Targeted Molecule for Disease-Activatable Proteolysis Targeting Chimeras and Targeted Radionuclide Therapy of Cancer. Journal of the American Chemical Society, 147(9), 7897-7907. https://doi.org/10.1021/jacs.4c18398

Vancouver

Zhang Y, Gu W, Chen W, Zhu J, Fan L, Zhang L, et al. A Dual-Targeted Molecule for Disease-Activatable Proteolysis Targeting Chimeras and Targeted Radionuclide Therapy of Cancer. Journal of the American Chemical Society. 2025;147(9):7897-7907. doi:10.1021/jacs.4c18398

BibTeX
@article{Zhang2025,
  author = {Zhang, Yuan and Gu, Wei and Chen, Wan and Zhu, Jieli and Fan, Longfei and Zhang, Liwen and Zhao, Liangyou and Miao, Qingqing},
  title = {A Dual-Targeted Molecule for Disease-Activatable Proteolysis Targeting Chimeras and Targeted Radionuclide Therapy of Cancer},
  journal = {Journal of the American Chemical Society},
  year = {2025},
  volume = {147},
  number = {9},
  pages = {7897--7907},
  doi = {10.1021/jacs.4c18398}
}
Kostenlos starten →